Health status impact on mortality and lung function decline in COPDGene smokers
W. Labaki (Ann Arbor, United States of America), T. Gu (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), X. Soler (San Diego, United States of America), S. Bhatt (Birmingham, United States of America), J. Bon (Pittsburgh, United States of America), T. Beaty (Baltimore, United States of America), J. Hokanson (Aurora, United States of America), D. Curran-Everett (Denver, United States of America), K. Lowe (Denver, United States of America), R. Bowler (Denver, United States of America), B. Make (Denver, United States of America), E. Regan (Denver, United States of America), F. Martinez (New York, United States of America), C. Hersh (Boston, United States of America), E. Silverman (Boston, United States of America), J. Crapo (Denver, United States of America), M. Han (Ann Arbor, United States of America)
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Labaki (Ann Arbor, United States of America), T. Gu (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), X. Soler (San Diego, United States of America), S. Bhatt (Birmingham, United States of America), J. Bon (Pittsburgh, United States of America), T. Beaty (Baltimore, United States of America), J. Hokanson (Aurora, United States of America), D. Curran-Everett (Denver, United States of America), K. Lowe (Denver, United States of America), R. Bowler (Denver, United States of America), B. Make (Denver, United States of America), E. Regan (Denver, United States of America), F. Martinez (New York, United States of America), C. Hersh (Boston, United States of America), E. Silverman (Boston, United States of America), J. Crapo (Denver, United States of America), M. Han (Ann Arbor, United States of America). Health status impact on mortality and lung function decline in COPDGene smokers. 508
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Association between lung function decline and occupational exposures in patients with COPD Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017
Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002
Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males Source: Eur Respir J 2005; 25: 618-625 Year: 2005
Six-year lung function observation and impact of smoking ban in healthy miners at high altitude (4000 meters) Source: Annual Congress 2013 –World tour of tobacco epidemiology Year: 2013
Does educational level influence lung function decline (Doetinchem Cohort Study)? Source: Eur Respir J 2009; 34: 940-947 Year: 2009
Effects of lifetime smoking patterns on nutrition, muscular and lung function in early COPD patients from the PAC-COPD cohort study Source: Eur Respir J 2007; 30: Suppl. 51, 283s Year: 2007
Health indicators and inflammation - a comparison of stable smoking and ex-smoking COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 52s Year: 2005
The effects of socioeconomic status on health outcomes in patients with COPD Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016
Health status and gender predict time to next exacerbation in patients with COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Lung function impairment, COPD hospitalisations and subsequent mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009
Gender impact on associations between socioeconomic status and lung function decline in a general population Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Regional lung function in nonsmokers and asymptomatic current and former smokers Source: ERJ Open Res, 5 (3) 00240-2018; 10.1183/23120541.00240-2018 Year: 2019
Influence of smoking on respiratory function and status of proteinas-inhibitory system in patients COPD Source: International Congress 2014 – Passive smoking, active smoking and COPD Year: 2014
Associations between lung function and dyspnoea, self-rated health, and mortality: the Nord-Trondelag health study Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD Year: 2008
Changes in performance status in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020
LATE-BREAKING ABSTRACT: Five items from the CAT questionnaire identify smokers with preserved lung function at higher risk for poor respiratory outcomes: An analysis of the SPIROMICS cohort Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015
Cardiovascular comorbidities based on impaired pulmonary function in non-smoking population Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020
Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Socioeconomic risk factors for lung function decline in a general population Source: Eur Respir J 2010; 36: 480-487 Year: 2010